ClinConnect ClinConnect Logo
Search / Trial NCT04469439

Impact of Sinus Surgery on Individuals With Cystic Fibrosis

Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Jul 9, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Chronic Rhinosinusitis Cystic Fibrosis Endoscopic Sinus Surgery

ClinConnect Summary

This clinical trial is studying the effects of endoscopic sinus surgery on individuals with cystic fibrosis who also suffer from a condition called chronic rhinosinusitis (CRS), which causes ongoing nasal and sinus problems. Researchers will look at how the surgery impacts patients' lung health and overall quality of life compared to those who are treated with medications only. Participants will be monitored to see how well they respond to their chosen treatment.

To be eligible for this study, participants should be between 18 and 99 years old, have a confirmed diagnosis of cystic fibrosis, and have symptoms of chronic rhinosinusitis that haven’t improved with medical treatment. Those who have had sinus surgery in the past year or plan to get follow-up care at a different facility won’t be eligible. If you decide to join, you can expect to provide some information about your health and treatment experiences over time. This trial is currently recruiting participants, so it's a great opportunity for those looking for relief from their symptoms.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Subjects between the ages of 18 years old (inclusive) and 99 years old (inclusive, subjects over the age of 89 will be recorded to be 89 years old).
  • 2. Diagnosed with cystic fibrosis as established by genetic testing combined with clinical assessment and/or sweat chloride
  • 3. Diagnosed with chronic rhinosinusitis by multidisciplinary sinusitis guidelines
  • 4. chronic rhinosinusitis symptoms persisting beyond initial medical treatment
  • 5. Counseled for endoscopic sinus surgery and ongoing medical therapy with each patient electing their preferred treatment
  • Exclusion Criteria:
  • 1. Underwent endoscopic sinus surgery in past 12 months
  • 2. Will obtain follow up care at non-participating institutions
  • 3. Unable to complete follow-up surveys

About University Of California, Los Angeles

The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.

Locations

Los Angeles, California, United States

Charleston, South Carolina, United States

Stanford, California, United States

Aurora, Colorado, United States

Chapel Hill, North Carolina, United States

Nashville, Tennessee, United States

Portland, Oregon, United States

Salt Lake City, Utah, United States

Denver, Colorado, United States

Patients applied

0 patients applied

Trial Officials

Daniel M Beswick, MD

Principal Investigator

University of California, Los Angeles

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials